Document:

Exhibit 10.11

 

ESCROW AGREEMENT (PUBLIC OFFERING)

 

THIS
AGREEMENT (this “Agreement”) is made this [date], by and among Baikang Biological Group Holdings
Limited (the “Issuer”) and the Underwriter whose name and address appears on the Information Sheet (as defined
herein) attached to this Agreement and Continental Stock Transfer & Trust Company, 1 State Street, 30th Floor, New York, New
York 10004 (the “Escrow Agent”).

 

W I T N E S S E T H:

 

WHEREAS,
the Issuer has filed with the Securities and Exchange Commission (the “Commission”) a Registration Statement
(the “Registration Statement”) covering a proposed public offering of its securities as described on the Information
Sheet;

 

WHEREAS,
the Underwriter proposes to offer the Securities, as agent for the Issuer, for sale to the public on a “best efforts”
only basis for at least the Minimum Securities Amount and Minimum Dollar Amount and at most the Maximum Securities Amount and Maximum
Dollar Amount and at the price per share or other unit all as set forth, on the Information Sheet;

 

WHEREAS
the Issuer and the Underwriter propose to establish an Escrow Account (the “Escrow Account”), to which subscription
monies which are received by the Escrow Agent from the Underwriter in connection with such public offering are to be credited,
and the Escrow Agent is willing to establish the Escrow Account and the terms are subject to the conditions hereinafter set forth;

 

WHEREAS,
the Escrow Agent has an agreement with JP Morgan Chase (the “Bank”) to establish a special Bank Account (defined
below) into which the subscription monies, which are received by the Escrow Agent from the Underwriter and credited to the Escrow
Account, are to be deposited; and

 

NOW,
THEREFORE in consideration of the premises and mutual covenants herein contained, the parties hereto hereby agree as
follows:

 

	1	Information Sheet. Each capitalized term not otherwise
defined in this Agreement shall have the meaning set forth for such term on the information sheet which is attached to this Agreement
and is incorporated by reference herein and made a part hereof (the “Information Sheet”).

 

	2	Establishment of the Bank Account.

 

	2.1	The Escrow Agent shall establish a non-interest bearing bank account at a branch of JP Morgan Chase
selected by the Escrow Agent, and bearing the designation set forth on the Information Sheet (heretofore defined as the “Bank
Account”). The purpose of the Bank Account is for (a) the deposit of all subscription monies (checks, or wire transfers)
which are received by the Underwriter from prospective purchasers of the Securities and are delivered by the Underwriter to the
Escrow Agent, (b) the holding of amounts of subscription monies which are collected through the banking system, and (c) the disbursement
of collected funds, all as described herein.

 

     

     

    

 

	2.2	On or before the date of the initial deposit in the Bank Account pursuant to this Agreement, the
Underwriter shall notify the Escrow Agent in writing of the effective date of the Registration Statement (the “Effective
Date”), and the Escrow Agent shall not be required to accept any amounts for credit to the Escrow Account or for deposit
in the Bank Account prior to its receipt of such notification.

 

	2.3	The offering period, which shall be deemed to commence on the Effective Date, shall consist of
the number of calendar days or business days set forth on the Information Sheet (the “Offering Period”). The
Offering Period shall be extended by an Extension Period (as defined in the Information Sheet) only if the Escrow Agent shall have
received joint written notice thereof from the Issuer and the Underwriter at least five (5) business days prior to the expiration
of the Offering Period. The Extension Period, which shall be deemed to commence on the next calendar day following the expiration
of the Offering Period, shall consist of the number of calendar days or business days set forth on the Information Sheet. The last
day of the Offering Period, or the last day of the Extension Period (if the Escrow Agent has received written notice thereof as
hereinabove provided), is referred to herein as the “Termination Date”. Except as provided in Section 4.3 hereof,
after the Termination Date the Underwriter shall not deposit, and the Escrow Agent shall not accept, any additional amounts representing
payments by prospective purchasers.

 

	3	Deposits to the Bank Account.

 

	3.1	The Underwriter shall promptly deliver to the Escrow Agent all monies in the form of checks or
wire transfers which it receives from prospective purchasers of the Securities by noon of the next business day following receipt
where internal supervisory review is conducted at the same location at which subscription documents and monies are received. Upon
the Escrow Agent’s receipt of such monies, they shall be credited to the Escrow Account. All checks delivered to the Escrow
Agent shall be made payable to “Baikang Biological Group Holdings Limited Escrow Account.” Any check payable other
than to the Escrow Agent as required hereby shall be returned to the prospective purchaser, or if the Escrow Agent has insufficient
information to do so, then to the Underwriter (together with any Subscription Information, as defined below, or other documents
delivered therewith) by noon of the next business day following receipt of such check by the Escrow Agent, and such check shall
be deemed not to have been delivered to the Escrow Agent pursuant to the terms of this Agreement.

 

	3.2	Promptly after receiving subscription monies as described in Section 3.1, the Escrow Agent shall
deposit the same into the Bank Account. Amounts of monies so deposited are hereinafter referred to as “Escrow Amounts”.
The Escrow Agent shall cause the Bank to process all Escrow Amounts for collection through the banking system. Simultaneously with
each deposit to the Escrow Account, the Underwriter (or the Issuer, if such deposit is made by the Issuer) shall inform the Escrow
Agent in writing of the name, address, and the tax identification number of the purchaser, the amount of Securities subscribed
for by such purchase, and the aggregate dollar amount of such subscription (collectively, the “Subscription Information”).

 

    	 	2	 

     

    

 

	3.3	The Escrow Agent shall not be required to accept for credit to the Escrow Account or for deposit
into the Bank Account checks which are not accompanied by the appropriate Subscription Information, which at minimum shall include
the name address, tax identification number and the number of shares/units. Wire transfers representing payments by prospective
purchasers shall not be deemed deposited in the Escrow Account until the Escrow Agent has received in writing the Subscription
Information required with respect to such payments.

 

	3.4	The Escrow Agent shall not be required to accept in the Escrow Account any amounts representing
payments by prospective purchasers, whether by check or wire, except during the Escrow Agent’s regular business hours.

 

	3.5	Only those Escrow Amounts, which have been deposited in the Bank Account and which have cleared
the banking system and have been collected by the Escrow Agent, are herein referred to as the “Fund”.

 

	3.6	If the proposed offering is terminated before the Termination Date, the Escrow Agent shall refund
any portion of the Fund prior to disbursement of the Fund in accordance with Article 4 hereof upon instructions in writing signed
by both the Issuer and the Underwriter.

 

	4	Disbursement from the Bank Account.

 

	4.1	Subject to Section 4.3 below, if by the close of regular banking hours on the Termination Date
the Escrow Agent determines that the amount in the Fund is less than the Minimum Dollar Amount or the Minimum Securities Amount,
as indicated by the Subscription information submitted to the Escrow Agent, then in either such case, the Escrow Agent shall promptly
refund to each prospective purchaser the amount of payment received from such purchaser which is then held in the Fund or which
thereafter clears the banking system, without interest thereon or deduction therefrom, by drawing checks on the Bank Account for
the amounts of such payments and transmitting them to the purchasers. In such event, the Escrow Agent shall promptly notify the
Issuer and the Underwriter of its distribution of the Fund.

 

	4.2	Subject to Section 4.3 below, if at any time up to the close of regular banking hours on the Termination
Date, the Escrow Agent determines that the amount in the Fund is at least equal to the Minimum Dollar Amount and represents the
sale of not less than the Minimum Securities Amount, the Escrow Agent shall promptly notify the Issuer and the Underwriter of such
fact in writing. The Escrow Agent shall promptly disburse the Fund, by drawing checks on the Bank Account in accordance with instructions
in writing signed by both the Issuer and the Underwriter as to the disbursement of the Fund, promptly after it receives such instructions.

 

	4.3	Upon disbursement of the total amount of the Fund pursuant to the terms of this Article 4, the
Escrow Agent shall be relieved of all further obligations and released from all liability under this Agreement. It is expressly
agreed and understood that in no event shall the aggregate amount of payments made by the Escrow Agent exceed the amount of the
Fund.

 

    	 	3	 

     

    

 

	5	Rights, Duties and Responsibilities of Escrow Agent. It
is understood and agreed that the duties of the Escrow Agent are purely ministerial in nature, and that:

 

	5.1	The Escrow Agent shall notify the Underwriter, on a daily basis, of the Escrow Amounts which have
been deposited in the Bank Account and of the amounts, constituting the Fund, which have cleared the banking system and have been
collected by the Escrow Agent.

 

	5.2	The Escrow Agent shall not be responsible for or be required to enforce any of the terms or conditions
of the underwriting agreement or any other agreement between the Underwriter and the Issuer nor shall the Escrow Agent be responsible
for the performance by the Underwriter or the Issuer of their respective obligations under this Agreement.

 

	5.3	The Escrow Agent shall not be required to accept from the Underwriter (or the Issuer) any Subscription
Information pertaining to prospective purchasers unless such Subscription Information is accompanied by checks, or wire transfers
meeting the requirements of Section 3.1, nor shall the Escrow Agent be required to keep records of any information with respect
to payments deposited by the Underwriter (or the Issuer) except as to the amount of such payments; however, the Escrow Agent shall
notify the Underwriter within a reasonable time of any discrepancy between the amount set forth in any Subscription Information
and the amount delivered to the Escrow Agent therewith. Such amount need not be accepted for deposit in the Escrow Account until
such discrepancy has been resolved.

 

	5.4	The Escrow Agent shall be under no duty or responsibility to enforce collection of any check delivered
to it hereunder. The Escrow Agent, within a reasonable time, shall return to the Underwriter any check received which is dishonored,
together with the Subscription Information, if any, which accompanied such check.

 

	5.5	The Escrow Agent shall be entitled to rely upon the accuracy, act in reliance upon the contents,
and assume the genuineness of any notice, instruction, certificate, signature, instrument or other document which is given
to the Escrow Agent pursuant to this Agreement without the necessity of the Escrow Agent verifying the truth or accuracy thereof.
The Escrow Agent shall not be obligated to make any inquiry as to the authority, capacity, existence or identity or any person
purporting to give any such notice or instructions or to execute any such certificate, instrument or other document.

 

	5.6	If the Escrow Agent is uncertain as to its duties or rights hereunder or shall receive instructions
with respect to the Bank Account, the Escrow Amounts or the Fund which, in its sole determination, are in conflict either with
other, instructions received by it or with any provision of this Agreement, it shall be entitled to hold the Escrow Amounts, the
Fund, or a portion thereof, in the Bank Account pending the resolution of such uncertainty to the Escrow Agent’s sole satisfaction,
by final judgment of a court or courts of competent jurisdiction or otherwise; or the Escrow Agent, at its sole option, may deposit
the Fund (and any other Escrow Amounts that thereafter become part of the Fund) with the Clerk of a court of competent jurisdiction
in a proceeding to which all parties in interest are joined. Upon the deposit by the Escrow Agent of the Fund with the Clerk of
any court, the Escrow Agent shall be relieved of all further obligations and released from all liability hereunder.

 

    	 	4	 

     

    

 

	5.7	The Escrow Agent shall not be liable for any action taken or omitted hereunder, or for the misconduct
of any employee, agent or attorney appointed by it, except in the case of willful misconduct or gross negligence. The Escrow Agent
shall be entitled to consult with counsel of its own choosing and shall not be Liable for any action taken, suffered or omitted
by it in accordance with the advice of such counsel.

 

	5.8	The Escrow Agent shall have no responsibility at any time to ascertain whether or not any security
interest exists in the Escrow Amounts, the Fund or any part thereof or to file any statement under the Uniform Commercial Code
with respect to the Fund or any part thereof.

 

	6	Amendment; Resignation. This Agreement may be altered
or amended only with the written consent of the Issuer, the Underwriter and the Escrow Agent.

 

	6.1	The Escrow Agent may resign for any reason upon thirty (30) business days’ written notice
to the Issuer and the Underwriter. Should the Escrow Agent resign as herein provided, it shall not be required to accept
any deposit, make any disbursement or otherwise dispose of the Escrow Amounts or the Fund, but its only duty shall be to hold the
Escrow Amounts until they clear the banking system and the Fund for a period of not more than five (5) business days following
the effective date of such resignation, at which time (a) if a successor escrow agent shall have been appointed and written notice
thereof (including the name and address of such successor escrow agent) shall have been given to the resigning Escrow Agent by
the Issuer, the Underwriter and such successor escrow agent, then the resigning Escrow Agent shall pay over to the successor escrow
agent the Fund, less any portion thereof previously paid out in accordance with this Agreement; or (b) if the resigning Escrow
Agent shall not have received written notice signed by the Issuer, the Underwriter and a successor escrow agent, then the resigning
Escrow Agent shall promptly refund the amount in the Fund to each prospective purchaser without interest thereon or deduction therefrom,
and the resigning Escrow Agent shall promptly notify the Issuer and the Underwriter in writing of its liquidation and distribution
of the Fund; whereupon, in either case, the Escrow Agent shall be relieved of all further obligations and released from all liability
under this Agreement. Without limiting the provisions of Section 8 hereof, the resigning Escrow Agent shall be entitled to be reimbursed
by the Issuer and the Underwriter for any actual expenses incurred in connection with its resignation, transfer of the Fund to
a successor escrow agent or distribution of the Fund pursuant to this Section 6.

 

	7	Representations and Warranties. The Issuer and the Underwriter
hereby jointly and severally represent and warrant to the Escrow Agent that:

 

	7.1	No party other than the parties hereto and the prospective purchasers have, or shall have, any
lien, claim or security interest in the Escrow Amounts or the Fund or any part thereof.

 

	7.2	No financing statement under the Uniform Commercial Code is on file in any jurisdiction claiming
a security interest in or describing (whether specifically or generally) the Escrow Amounts or the Fund or any part thereof.

 

    	 	5	 

     

    

 

	7.3	The Subscription Information submitted with each deposit shall, at the time of submission and at
the time of disbursement of the Fund, be deemed a representation and warranty that such deposit represents a bona fide payment
by the purchaser described therein for the amount of securities in such described as Subscription Information.

 

	7.4	All of the information contained in the Information Sheet is, as of the date hereof, and will be,
at the time of any disbursement of the Fund, true and correct.

 

	7.5	Reasonable controls have been established and required due diligence performed to comply with “Know
Your Customer” regulations, USA Patriot Act, Office of the Foreign Asset Control (OFAC) regulations and the Bank Secrecy
Act.

 

	8	Fees and Expenses. The Escrow Agent shall be entitled
to the Escrow Agent Fees set forth on the Information Sheet, payable as and when stated therein. In addition, the Issuer and the
Underwriter jointly and severally agree to reimburse the Escrow Agent for any reasonable expenses incurred in connection with this
Agreement, including, but not limited to, reasonable counsel fees. Upon receipt of the Minimum Dollar Amount, the Escrow Agent
shall have a lien upon the Fund to the extent of its fees for services as Escrow Agent.

 

	9	Indemnification and Contribution.

 

	9.1	The Issuer and the Underwriter (collectively referred to as the “Indemnitors”)
jointly and severally agree to indemnify the Escrow Agent and its officers, directors, employees, agents and shareholders (collectively
referred to as the “Indemnitees”) against, and hold them harmless of and from, any and all loss, liability,
cost, damage and expense, including without limitation, reasonable counsel fees, which the Indemnitees may suffer or incur by reason
of any action, claim or proceeding brought against the Indemnitees arising out of or relating in any way to this Agreement or any
transaction to which this Agreement relates, unless such action, claim or proceeding is the result of the willful misconduct or
gross negligence of the Indemnitees.

 

	9.2	If the indemnification provided for in Section 9.1 is applicable, but for any reason is held to
be unavailable, the Indemnitors shall contribute such amounts as are just and equitable to pay, or to reimburse the Indemnitees
for, the aggregate of any and all losses, liabilities, costs, damages and expenses, including counsel fees, actually incurred by
the Indemnitees as a result of or in connection with, and any amount paid in settlement of, any action, claim or proceeding arising
out of or relating in any way to any actions or omissions of the Indemnitors.

 

	9.3	The provisions of this Article 9 shall survive any termination of this Agreement, whether by disbursement
of the Fund, resignation of the Escrow Agent or otherwise.

 

	10	Governing Law and Assignment. This
Agreement shall be construed in accordance with and governed by the laws of the State of New York and shall be binding upon the
parties hereto and their respective successors and assigns; provided, however, that any assignment or transfer by any party of
its rights under this Agreement or with respect to the Escrow Amounts or the Fund shall be void as against the Escrow Agent unless
(a) written notice thereof shall be given to the Escrow Agent; and (b) the Escrow Agent shall have consented in writing to such
assignment or transfer.

 

    	 	6	 

     

    

 

	11	Notices. All notices required to be given in connection
with this Agreement shall be sent by registered or certified mail, return receipt requested, electronic mail (“e-mail”)
with PDF attachment executed by an authorized signer of the Party/Parties to the e-mail address given below or by hand delivery
with receipt acknowledged, or by the Express Mail service offered by the United States Post Office, and addressed, if to the Issuer
or the Underwriter, at their respective addresses set forth on the Information Sheet, and if to the Escrow Agent, at its address
set forth above, to the attention of the Trust Department. The notice shall be deemed to have been duly given: (a) when received
if personally delivered; (b) the day after it is sent, if sent for next day delivery to a domestic address by a recognized overnight
delivery service (e.g., Federal Express); and (c) upon receipt, if sent by certified or registered mail, return receipt
requested. The commencement of any notice periods set forth in a notice shall begin upon the deemed delivery date of such notice.

 

	12	Severability. If any provision of this Agreement or the
application thereof to any person or circumstance shall be determined to be invalid or unenforceable, the remaining provisions
of this Agreement or the application of such provision to persons or circumstances other than those to which it is held invalid
or unenforceable shall not be affected thereby and shall be valid and enforceable to the fullest extent permitted by law.

 

	13	Execution in Several Counterparts. This Agreement may
be executed in several counterparts or by separate instruments, and all of such counterparts and instruments shall constitute one
agreement, binding on all of the parties hereto.

 

	14	Entire Agreement. This Agreement constitutes the entire
agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings
(written or oral) of the parties in connection therewith.

 

    	 	7	 

     

    

 

IN WITNESS WHEREOF, the undersigned have
executed this Agreement as of the day and year first above written.

 

 

	THE ISSUER	 	THE ESCROW AGENT
	 	 	 
	 	 	 
	BAIKANG BIOLOGICAL GROUP HOLDINGS LIMITED	 	CONTINENTAL STOCK TRANSFER & TRUST COMPANY
	 	 	 
	 	 	 
	By:	 	 	By:	 
	 	Name:	 	 	Name:
	 	Title:	 	 	Title:
	 	 	 
	 	 	 
	THE UNDERWRITER	 	 
	 	 	 
	JOSEPH STONE CAPITAL, LP	 	 
	 	 	 
	 	 	 
	By:	 	 	 
	 	Name:	 	 
	 	Title:	 	 

 

 

[Signature Page of Escrow Agreement in
re Baikang IPO]

 

     

     

    

 

EXHIBIT A

 

ESCROW AGREEMENT INFORMATION SHEET

 

	1.	The Issuer

Name:
Baikang Biological Group Holdings Limited

Address: Ginkgo Biomedical Science & Technology
Industrial Park, Pizhou, Jiangsu Province, People’s Republic of China 221300

 

	2.	The Underwriter

Name: Joseph Stone Capital, LP

Address: 200 Old Country Rd,
Suite 610, Mineola, NY 11501

 

	3.	The Securities

Description of the Securities
to be offered: Up to 2,400,000 shares of the Issuer.

 

	4.	Minimum Securities Amount and Conditions Required
for Disbursement of the Escrow Account

Aggregate
dollar amount which must be collected before the Escrow Account may be disbursed to the Issuer: US$8,000,000 (“Minimum
Dollar Amount”)

 

Maximum
Securities Amount and Conditions Required for Disbursement of the Escrow Account US$12,000,000 (“Maximum Dollar
Amount”)

 

	5.	Plan of Distribution of the Securities

Initial Offering Period: Through
March 28, 2020

Extension Period, if any: Until
[date]

 

	6.	Title of Escrow Account

“Baikang Biological Group
Holdings Limited Escrow Account”

 

	7.	Escrow Agent Fees and Charges

$5,500 for the first 6 months:
$2,750.00 payable at signing of the Escrow Agreement, plus $2,750.00 at the Closing. (Note: $250.00 online “view only”
access to the bank account is included). A fee of $500 will be payable for document review services related to each amendment/extension
to the Escrow Agreement. In addition, the Escrow Agent shall be paid a fee of $500.00 for each additional closing beyond the Initial
Offering Period. Should the Escrow Agent continue for more than six months, the Escrow Agent shall receive a fee of $600.00 per
month, or any portion thereof, payable in advance or the first business day of the month.

 

Distribution charges:

$10.00 per check

$50.00 per wire

$100.00 per check returned (NSF)
check

$100.00 lost check replacement
fee

$50.00 per DWAC (share movement
to DTC)

$10.00 per share certificateExhibit 10.12

 

Form of Lock-Up Agreement

 

[___], 2019

Joseph Stone Capital, LLC

200 Old Country Rd, Suite 610

Mineola, NY 11501

 

Re: Proposed Public Offering by Baikang Biological
Group Holdings Limited

 

Ladies and Gentlemen:

 

The undersigned, a shareholder,
director or officer of Baikang Biological Group Holdings Limited, a British Virgin Islands company (the “Company”),
understands that Joseph Stone Capital, LLC (the “Underwriter”) will act as an underwriter to carry out the
proposed public offering (the “Offering”) of the Company’s common shares, par value $0.001 each (the
“Securities”). In recognition of the benefit that the Offering will confer upon the undersigned, and for other
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned agrees with the
Underwriter that, without the prior written consent of the Underwriter, during a period of twelve (12) months beginning on the
commencement of trading of the Securities on the Nasdaq Capital Market (the “Lock-Up Period”), the undersigned
will not, without the prior written consent of the Underwriter, directly or indirectly (i) offer, pledge, sell, contract to sell,
sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase
or otherwise transfer or dispose of any securities of the Company (including the issuance of shares of Securities upon the exercise
of options) (collectively, the “Lock-Up Securities”), whether now owned or hereafter acquired by the undersigned
or with respect to which the undersigned has or hereafter acquires the power of disposition, or file, or cause to be filed, any
registration statement under the Securities Act of 1933, as amended, with respect to any of the foregoing or (ii) enter into any
swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence
of ownership of the Lock-Up Securities, whether any such swap or transaction described in clause (i) or (ii) above is to be settled
by delivery of the Lock-Up Securities or such other securities, in cash or otherwise.

 

Notwithstanding the foregoing,
and subject to the conditions below, the undersigned may transfer the Lock-Up Securities without the prior written consent of the
Underwriter as follows, provided that (a) the Underwriter receives a signed lock-up agreement for the balance of the Lock-Up Period
from each donee, trustee or transferee, as the case may be, (b) any such transfer in (1), (2) or (3) below shall not involve a
disposition for value, (c) such transfers are not required to be reported during the Lock-Up Period in any public report or filing
with the Securities and Exchange Commission, or otherwise (other than a required filing on Schedule 13D or Schedule 13G), and (4)
the undersigned does not otherwise voluntarily effect any public filing or report regarding such transfers:

 

(1)          as a bona fide gift
or gifts; or

 

(2)          to any trust or other
entity for the direct or indirect benefit of, or wholly-owned by, the undersigned or the immediate family of the undersigned (for
purposes of this lock-up agreement, “immediate family” shall mean any relationship by blood, marriage or adoption,
not more remote than first cousin); or

 

    	 	 	 

     

    

 

(3)          by will, other testamentary
document or intestate succession to the legal representative, heir, beneficiary or a member of the immediate family of the undersigned;

 

(4)          by operation of law
pursuant to a qualified domestic order or in connection with a divorce settlement; or

 

(5)          pursuant to a trading
plan established pursuant to Rule 10b5-1 of the Exchange Act;

 

 (6)          by
transactions relating to common shares acquired in open market transactions after the completion of the Public Offering, or the
exercise of any stock option to purchase common shares pursuant to any benefit plan of the Company; 

 

(7)          if the undersigned,
directly or indirectly, controls a corporation, partnership, limited liability company or other business entity, any transfers
of Lock-Up Securities to any such corporation, partnership, limited liability company or other business entity, or any shareholder,
partner or member of, or owner of similar equity interests in, the same, as the case may be;

 

(8)           if the undersigned
is a corporation, partnership, limited liability company or other business entity, any transfer made by the undersigned (a) in
connection with the sale or other bona fide transfer in a single transaction of all or substantially all of the undersigned’s
capital stock, partnership interests, membership interests or other similar equity interests, as the case may be, or all or substantially
all of the undersigned’s assets, in any such case not undertaken for the purpose of avoiding the restrictions imposed by
this Agreement or (b) to another corporation, partnership, limited liability company or other business entity so long as the transferee
is an affiliate (as defined below) of the undersigned and such transfer is not for value;

 

 (9)          the
occurrence after the date hereof of any of (a) an acquisition by an individual or legal entity or “group” (as described
in Rule 13d-5(b)(1) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”))
of effective control (whether through legal or beneficial ownership of capital stock of the Company, by contract or otherwise)
of 100% of the voting securities of the Company, (b) the Company merges into or consolidates with any other entity, or any entity
merges into or consolidates with the Company, (c) the Company sells or transfers all or substantially all of its assets to another
person, or (d) provided, that, the Common Shares received upon any of the events set forth in clauses (a) through (c) above shall
remain subject to the restrictions provided for in this Agreement; 

 

(10)        the Offering; or

 

(11)        transfers consented
to, in writing by the Underwriter.

 

    	 	 	 

     

    

 

Notwithstanding the foregoing, if:

 

(1)          during the last 17
days of the Lock-Up Period, the Company issues an earnings release or material news or a material event relating to the Company
occurs; or

 

(2)          prior to the expiration
of the Lock-Up Period, the Company announces that it will release earnings results or becomes aware that material news or a material
event will occur during the 16-day period beginning on the last day of the Lock-Up Period,

 

the restrictions imposed by this lock-up agreement
shall continue to apply until the expiration of the 18-day period beginning on the issuance of the earnings release or the occurrence
of the material news or material event, as applicable, unless the Underwriter waives, in writing, such extension.

 

The undersigned hereby
acknowledges and agrees that written notice of any extension of the Lock-Up Period pursuant to the previous paragraph will be delivered
by the Underwriter to the Company and that any such notice properly delivered will be deemed to have been given to, and received
by, the undersigned. The undersigned further agrees that, prior to engaging in any transaction or taking any other action that
is subject to the terms of this lock-up agreement during the period from the date of this lock-up agreement to and including the
34th day following the expiration of the Lock-Up Period, it will give notice thereof to the Company and will not consummate such
transaction or take any such action unless it has received written confirmation from the Company that the Lock-Up Period (as may
have been extended pursuant to the previous paragraph) has expired.

 

The undersigned understands
that, if the Offering shall terminate or be terminated prior to payment for and delivery of the Securities, the undersigned shall
be released from all obligations set forth herein.

 

The undersigned also agrees
and consents to the entry of stop transfer instructions with the Company’s transfer agent and registrar against the transfer
of the Lock-Up Securities except in compliance with the foregoing restrictions.

 

The undersigned, whether
or not participating in the Offering, understands that the Underwriter is proceeding with the Offering in reliance upon this lock-up
agreement.

 

This lock-up agreement
shall be governed by and construed in accordance with the laws of the State of New York, without regard to the conflict of laws
principles thereof.

 

[Signature page follows]

 

	 	Very truly yours,
	 	 
	 	 
	 	(Name - Please Print)
	 	 
	 	 
	 	(Signature)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}]]